PsyTech VR presented its virtual reality exposure therapy platform at the ACBS World Conference 2025, demonstrating the technology's application for treating multiple mental health conditions. Advisory board members Dr. Gwilym Roddick and Dr. Melanie Smith engaged with clinicians to illustrate how VR can bring therapeutic interventions to life through immersive experiences. Conference attendees explored the platform firsthand, experiencing its capabilities for treating phobias, anxiety and stress disorders, obsessive-compulsive disorder, post-traumatic stress disorder, and addictions and anger management.
The platform incorporates science-backed protocols designed to ensure both usability and clinical effectiveness for mental health professionals. Many attendees expressed interest in integrating VR technology into their practices to enhance the effectiveness and engagement of cognitive behavioral therapy. Dr. Roddick emphasized VR's potential to create structured, immersive, and personalized environments for exposure therapy, advancing evidence-based mental health care approaches. The demonstration highlighted how VR technology can transform traditional therapeutic methods by providing controlled, repeatable exposure scenarios that might be difficult or impossible to recreate in conventional settings.
Clinical applications demonstrated at the conference included specific protocols for various conditions, with the platform offering customizable scenarios that therapists can adapt to individual patient needs. This flexibility allows for gradual exposure progression, a key component of effective exposure therapy. The technology's ability to simulate real-world situations in a controlled environment provides therapists with new tools for assessment and treatment planning. Research supporting VR exposure therapy continues to grow, with studies showing effectiveness comparable to traditional methods while offering advantages in accessibility and standardization.
Mental health professionals attending the conference noted the platform's potential to address treatment barriers, including geographical limitations and resource constraints. By bringing therapy to life through immersive technology, PsyTech VR aims to expand access to evidence-based interventions. The company's approach focuses on maintaining clinical rigor while leveraging technological advancements to improve patient outcomes. As VR technology becomes more sophisticated and accessible, its integration into mental health practice represents a significant development in therapeutic innovation. The conference demonstration provided clinicians with practical insights into implementing VR technology within existing treatment frameworks, highlighting both current capabilities and future potential for the field.
